News

MapLight Therapeutics Sets Price for Its Highly Anticipated IPO

MapLight Therapeutics Sets Price for Its Highly Anticipated IPO

MapLight Therapeutics IPO Pricing Announcement

MapLight Therapeutics, Inc., a biopharmaceutical company committed to enhancing the lives of those struggling with severe central nervous system disorders, has revealed the pricing details for its initial public offering (IPO). The company plans to offer 14,750,000 shares of common stock at a starting price of $17.00 per share. Additionally, it has provided underwriters a 30-day option to buy up to 2,212,500 more shares at the same offering price, minus any applicable underwriting discounts and commissions.

Concurrent Private Placement Details

Alongside the IPO, MapLight will also conduct a concurrent private placement. This entails the sale of 476,707 shares of common stock at the IPO price to affiliates of Goldman Sachs & Co. LLC. However, shares sold in this private placement will not be registered under the Securities Act of 1933. The anticipated gross proceeds from both the IPO and the private placement are projected to reach $258.9 million, before accounting for the underwriters' options.

Trading and Offering Expectations

The initiation of trading for the shares on the Nasdaq Global Market is expected to begin shortly, scheduled for October 27. The shares will trade under the symbol "MPLT". The company expects to finalize the offering by October 28, pending the completion of standard closing conditions.

Role of Managing Underwriters

For this offering, Morgan Stanley, Jefferies, Leerink Partners, and Stifel are serving as joint book-running managers. Their experienced roles in guiding this IPO underline the strategic importance of this event for MapLight Therapeutics.

Company Background and Product Candidates

MapLight Therapeutics focuses on providing innovative solutions for patients experiencing debilitating conditions related to the central nervous system. Founded by leading figures in psychiatry and neuroscience, the company aims to develop circuit-specific pharmacotherapies that are currently scarce. The flagship product candidate, ML-007C-MA, is a combination of an investigational M1/M4 muscarinic agonist and a peripheral anticholinergic, which is now undergoing Phase 2 clinical trials to target schizophrenia and Alzheimer's disease psychosis.

Investor Relations and Further Information

All relevant registration documentation for these securities has been filed with the U.S. Securities and Exchange Commission. This filing became automatically effective as of October 25. Interested parties can access the final prospectus for detailed information once it is available.

Should investors wish to follow up or gather more insights, they can reach out to the investor relations team via email at investors@maplightrx.com. Media inquiries can be directed to media@maplightrx.com.

Frequently Asked Questions

What is the price of MapLight's IPO?

The initial public offering price is set at $17.00 per share.

When does trading begin for MapLight Therapeutics?

Trading is expected to start on October 27 on the Nasdaq Global Market.

How many shares is MapLight offering in its IPO?

MapLight is offering a total of 14,750,000 shares in the IPO.

Who are the underwriters for this offering?

Morgan Stanley, Jefferies, Leerink Partners, and Stifel are the joint book-running managers for the IPO.

What is MapLight's primary focus?

MapLight Therapeutics aims to develop therapies for patients suffering from severe central nervous system disorders.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Clean Energy: How COP31 Can Change the Future

Updated Category News Views 97

Global Warming: A Battle Heating Up Fast It's like trying to run uphill while carrying the baggage of outdated promises. We’ve got business bigwigs rallying at COP31, demanding the world to get serious about clean energy. If they don’t, we're looking at warming rocketing up to 2.6°C come year 2100. Who's listening though? The Call for Clean Electrification This mob,...

Continue Reading
Jersey Teamsters Stand Firm for Fair Health Worker Deal

Updated Category News Views 63

ImageCare Workers Ready to Strike Normally, when we hear about health care, we're pretending it’s this well-oiled machine. But here we are, witnessing techs and aides at ImageCare gearing up to strike for the first time. Sussex County’s finest have had it up to their ears negotiating for a union contract that doesn’t treat them like an afterthought. Two-Year...

Continue Reading
Tiana Marbuery Joins ALTA Division at Partner

Updated Category News Views 0

Tiana Marbuery Dives In at Partner Forget flashy office parties and buzzword bingo. Today’s gig's all about substance. Partner Engineering and Science, Inc. just snagged themselves a heavy-hitter with Tiana Marbuery joining the ranks as Technical Director in their ALTA Division. This ain't a small fry deal—Marbuery's packing over eight years of hard-earned chops in...

Continue Reading
SuperCom's Q3 2026 Results: Key Details to Watch

Updated Category News Views 33

SuperCom's Financial Report: What's on the Horizon? It's not every day that a company rolls out its financial results with expectations as layered as a lasagna, especially when you're talking about a player as entangled in IoT and cybersecurity as SuperCom. They're planning to drop their third quarter 2026 financials on November 12. It's a date for the calendar because,...

Continue Reading
SAGA Metals Enters Decision-Making Circles in Canada

Updated Category News Views 63

Stepping into the Big Leagues Seems like SAGA Metals is making a gutsy move, stepping into some heavy-hitting circles. They just hitched their wagon to the Canadian Chamber of Commerce's Critical Minerals Council. That's not just a foot in the door; that's walking right into the room where national policy gets cooked up. Joining forces here could be their ticket to...

Continue Reading
Tripadvisor Faces Investigation Over Securities Violations

Updated Category News Views 85

Tripadvisor's Stock Dive: Investor Panic or Opportunity? Woah, if you had a stake in Tripadvisor (NASDAQ: TRIP) recently, you know it hasn't been a walk in the park. Shares took a nosedive of over 20% on November 5, 2026, after they unveiled a frightening $313.1 million net loss for the third quarter. What stirred the pot, you ask? Well, toss in a goodwill impairment...

Continue Reading
Zylox-Tonbridge's Bold Move with LifeTech Investment

Updated Category News Views 104

An Investment That's Turning Heads Alright, here's a curveball for ya. Zylox-Tonbridge and GL Capital are throwing down a cool HK$1.482 billion into LifeTech Scientific, aiming for a high-stakes play in the vascular and structural heart field. This isn't just peanuts or pocket change; it's a concerted push to carve out a new landscape in China with something akin to a...

Continue Reading
Mount St. Mary's University Climbs in College Rankings

Updated Category News Views 19

Moving Up the Rankings Ladder Mount St. Mary's University has been making waves not only on campus but in the highly competitive world of college rankings. The institution has managed to climb the ranks in the 2026–27 U.S. News & World Report Best Colleges rankings, a feat that's not just some idle happenstance. The Numbers Speak If you've been paying attention, the...

Continue Reading
Luxury Dog Resort Opens in Dallas on November 14th

Updated Category News Views 44

Dallas Pooches Get Star Treatment It's about time our furry pals in Dallas got a piece of high society. This ain't your run-of-the-mill doggie daycare opening a new outlet. The Wags Club, with its roots deep in Los Angeles luxury, is setting up shop near Love Field, giving Texan pups a taste of the good life. Visitors on November 14 better dress their best, and that's not...

Continue Reading
Andersen's Window Revamp: Addressing Demand Surge

Updated Category News Views 53

Portfolio Boost: Adapting to Market Needs If you're sniffing around the windows business, there's a fresh breeze of innovation blowing from Andersen. They're not just sitting around drumming their fingers—they're rolling up their sleeves and fine-tuning their offerings. With half of homeowners swinging a hammer on renovations last year, the company sees an opportunity...

Continue Reading

Top 5 Most Recently Viewed Articles

Lunar New Year in China: Celebrations Amid Economic Concerns

Updated Category News Views 270

Lunar New Year in China: Celebrations Amid Economic Concerns As the Lunar New Year approaches, millions of people across China are making their way to their hometowns, bringing gifts and the spirit of celebration. This year's preparations seem more vibrant than ever, yet they come shadowed by economic uncertainty. Journey Home for Family Reunions Chinese citizens are...

Continue Reading
Graphite One Completes Successful Financing and Growth Plans

Updated Category News Views 381

Graphite One Closes Financing for Strategic Growth Graphite One Inc. (TSXV: GPH, OTCQX: GPHOF) has recently embarked on an exciting new chapter as they announce the completion of a significant private placement financing. The company's efforts are poised to propel its Graphite Creek project, enhancing its capabilities as one of the premier suppliers of high-grade anode...

Continue Reading
DFDS December Volumes Show Strong Growth Across Metrics

Updated Category News Views 132

DFDS December Volumes Show Strong Growth Across Metrics Ferry – Freight: In December, DFDS reported total freight volumes were 6.4% higher compared to the previous year. This figure accounts for adjustments following the addition of new routes, including those in the Strait of Gibraltar, the closure of Calais-Tilbury in the prior year, and the opening of the...

Continue Reading
Equinix Announces Upcoming Conference Call for Q4 Results

Updated Category News Views 91

Equinix to Host Q4 and Full-Year Results Conference Call Equinix, Inc. (Nasdaq: EQIX), recognized globally as a leader in digital infrastructure, has exciting updates regarding their forthcoming quarterly conference call. This event is scheduled for Wednesday, February 12, 2025, at 5:30 p.m. ET. During this call, Equinix will discuss its performance for the fourth quarter...

Continue Reading
CPC Introduces Innovative Aseptic Connectors for CGT Processing

Updated Category News Views 149

CPC Unveils Cutting-Edge Connectors for Cell and Gene Therapy CPC (Colder Products Company), a leading expert in connection technologies for biopharmaceutical processing, is excited to announce the launch of its groundbreaking MicroCNX® Nano Series aseptic connectors. These innovative connectors are specially designed to revolutionize sterile processing in the growing...

Continue Reading